Atorvastatin Epoxy Pyrrolooxazin 7-Hydroxy Analog

CAS No :

1315629-79-8 (KLS-A06002)

Molecular Formula:

C33H35FN2O7

Molecular Weight:

556.6

Chemical Name:

(3R)-4-(1b-(4-Fluorophenyl)-7-hydroxy-7-isopropyl-1a-phenyl-7a-(phenylcarbamoyl)hexahydro-1aH-oxireno[2′,3′:3,4]pyrrolo[2,1-b][1,3]oxazin-3-yl)-3-hydroxybutanoic acid

Add to Enquiry Basket
Product Enquiry

Related Products

Atorvastatin Acid Isopropyl Ester

CAS No: ​ 1035205-25-4

Molecular Formula:​ C36H41FN2O5

Molecular Weight: ​600.7

Inv. Status:​


Add to Enquiry Basket

Atorvastatin EP Impurity E

CAS No: ​1428118-38-0

Molecular Formula:​ C33H34FN2O5Na

Molecular Weight: ​557.6 : 23.0

Inv. Status:​


Add to Enquiry Basket

Atorvastatin EP Impurity P

CAS No: ​581772-29-4

Molecular Formula:​ C36H39FN2O5

Molecular Weight: ​598.7

Inv. Status:​


Add to Enquiry Basket

Atorvastatin EP Impurity N

CAS No: ​134395-00-9

Molecular Formula:​ C37H43FN2O5

Molecular Weight: ​614.9

Inv. Status:​


Add to Enquiry Basket

Difluoro Atorvastatin Acetonide tert-Butyl Ester

CAS No: ​693793-87-2

Molecular Formula:​ C40H46F2N2O5

Molecular Weight: ​672.8

Inv. Status:​


Add to Enquiry Basket

Atorvastatin Epoxy Pyrrolooxazin 6-Hydroxy Analog

CAS No: ​1316291-19-6

Molecular Formula:​ C33H34FN2NaO7

Molecular Weight: ​612.62

Inv. Status:​


Add to Enquiry Basket

Atorvastatin EP Impurity A

CAS No: ​1516864-05-3

Molecular Formula:​ C33H35N2O5 : Na

Molecular Weight: ​539.7 : 23.0

Inv. Status:​


Add to Enquiry Basket

Atorvastatin Epoxy Tetrahydrofuran Analog

CAS No: ​873950-19-7

Molecular Formula:​ C26H24FNO5

Molecular Weight: ​449.47

Inv. Status:​


Add to Enquiry Basket

Atorvastatin EP Impurity M

CAS No: ​1146977-93-6

Molecular Formula:​ C35H39FN2O5

Molecular Weight: ​586.69

Inv. Status:​


Add to Enquiry Basket

API – Impurities | Specialty Chemicals

Dribbble Pinterest

About

Kemiezen Lifesciences is established with a zeal of support the world with the best chemistry solutions with a group of dedicated scientists having 15 years of experience in the pharmaceutical industry.

Contact Us